Genmab — December 2024

[E_L]

From Uncertainty to Strength: Navigating Life with Cervical Cancer https://walterborolive.com/premium/brandpoint/stories/from-uncertainty-to-strength-navigating-life-with-cervical-cancer,134371 - Sponsored by Pfizer Inc. and Genmab; i am not sure that is allowed in Europe , sort of paid advertising with patients

[E_L]

To learn more about the innovaTV 301 trial and its impact on cervical cancer treatment, watch the video https://www.primrmed.com/cancer-education/the-innovatv-301-trial-for-patients-with-cervical-cancer https://www.primrmed.com/blog-post/breakthrough-treatment-for-metastatic-cervical-cancer-the-innovatv-301-trial

[E_L]

our old "friend" morphosys - Novartis says 330 jobs hit as it closes MorphoSys sites https://www.reuters.com/business/healthcare-pharmaceuticals/some-330-jobs-hit-novartis-closes-morphosys-wiwo-reports-2024-12-19/?taid=6763f5afdd611200016084a9&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter

[E_L]

small new Ph2
trial - Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma https://clinicaltrials.gov/study/NCT06575686

[ProinvestorNEWS]

Genmab får hævet anbefaling til "market perform" af Bernstein https://proinvestor.com/investornyt/1256245/genmab-far-haevet-anbefaling-til-market-perform-af-bernstein

[E_L]

every investment fund suddenly underweight Danish pharma and biotech, just like that...

[E_L]

"underweight" ,
pun intended

[Sukkeralf]

We could hope for some new shares holders if people get tired of obesity stocks for a while

[E_L]

yes, feel sorry for the Novo holders, but you are very welcome here at genmab...

[Bulder]

Especially those who had bull x 10

[Bulder]

On the other hand bear x 10 is up 180%. But in Nordnet it was only 2 persons. 66 persons had Bull x 10.

[Bulder]

This morning somebody sold 900 bear x10 for 44 dkk

[Bulder]

2 hours later the Price was 135. Hard luck.

[E_L]

the joys of leverage...pfff... also, horrible timing to bring this news on what is possibly the last active trading day of the year for many and also a big option expiration...

[E_L]

Japanese GEN1042 trial adds 2 arms , but i can not immediately see the difference between cohorts 1&2 and 3&4... https://clinicaltrials.gov/study/NCT06057038?tab=history&a=13&b=14&compareMode=sideBySide#version-content-panel

[E_L]

always glad to see activity on GEN1042, as we are waiting to hear what will happen to this program... activity means it isn't shut down yet lol

[E_L]

maybe they made a mistake and they forgot to add 'Dose Expansion' of something for cohort 3&4

[lahn1]

It a relief to see you still have some positivity in you EL

[lahn1]

Currently returning some of the kids Christmas presents at the store. Maybe next year

[E_L]